Literature DB >> 9588600

Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination.

M H Tuszynski1, N Weidner, M McCormack, I Miller, H Powell, J Conner.   

Abstract

Schwann cells naturally support axonal regeneration after injury in the peripheral nervous system, and have also shown a significant, albeit limited, ability to support axonal growth and remyelination after grafting to the central nervous system (CNS). It is possible that Schwann cell-induced axonal growth in the CNS could be substantially increased by genetic manipulation to secrete augmented amounts of neurotrophic factors. To test this hypothesis, cultured primary adult rat Schwann cells were genetically modified using retroviral vectors to produce and secrete high levels of human nerve growth factor (NGF). These cells were then grafted to the midthoracic spinal cords of adult rats. Findings were compared to animals that received grafts of nontransduced Schwann cells. Spinal cord lesions were not placed prior to grafting because the primary aim of this study was to examine features of grafted Schwann cell survival, growth, and effects on host axons. In vitro prior to grafting, Schwann cells secreted 1.5+/-0.1 ng human NGF/ml/10(6) cells/day. Schwann cell transplants readily survived for 2 wk to 1 yr after in vivo placement. Some NGF-transduced grafts slowly increased in size over time compared to nontransduced grafts; the latter remained stable in size. NGF-transduced transplants were densely penetrated by primary sensory nociceptive axons originating from the dorsolateral fasciculus of the spinal cord, whereas control grafts showed significantly fewer penetrating sensory axons. Over time, Schwann cell grafts also became penetrated by TH- and DBH-labeled axons of putative coerulospinal origin, unlike control cell grafts. Ultrastructurally, axons in both graft types were extensively myelinated by Schwann cells. Grafted animals showed no changes in gross locomotor function. In vivo expression of the human NGF transgene was demonstrated for periods of at least 6 m. These findings demonstrate that primary adult Schwann cells 1) can be transduced to secrete augmented levels of neurotrophic factors, 2) survive grafting to the CNS for prolonged time periods, 3) elicit robust growth of host neurotrophin-responsive axons, 4) myelinate CNS axons, and 5) express the transgene for prolonged time periods in vivo. Some grafts slowly enlarge over time, a feature that may be attributable to the propensity of Schwann cells to immortalize after multiple passages. Transduced Schwann cells merit further study as tools for promoting CNS regeneration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588600     DOI: 10.1177/096368979800700213

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.139


  25 in total

Review 1.  Growth factor delivery for tissue engineering.

Authors:  J E Babensee; L V McIntire; A G Mikos
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

Review 2.  Molecular targets in spinal cord injury.

Authors:  Stefan Klussmann; Ana Martin-Villalba
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

Review 3.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

Review 4.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

5.  Transduced Schwann cells promote axon growth and myelination after spinal cord injury.

Authors:  Kevin L Golden; Damien D Pearse; Bas Blits; Maneesh S Garg; Martin Oudega; Patrick M Wood; Mary Bartlett Bunge
Journal:  Exp Neurol       Date:  2007-07-13       Impact factor: 5.330

6.  Long-term characterization of axon regeneration and matrix changes using multiple channel bridges for spinal cord regeneration.

Authors:  Hannah M Tuinstra; Daniel J Margul; Ashley G Goodman; Ryan M Boehler; Samantha J Holland; Marina L Zelivyanskaya; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2013-12-11       Impact factor: 3.845

Review 7.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

Review 8.  Novel combination strategies to repair the injured mammalian spinal cord.

Authors:  Mary Bartlett Bunge
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

9.  c-Jun gene-modified Schwann cells: upregulating multiple neurotrophic factors and promoting neurite outgrowth.

Authors:  Liangliang Huang; Xin Quan; Zhongyang Liu; Teng Ma; Yazhen Wu; Jun Ge; Shu Zhu; Yafeng Yang; Liang Liu; Zhen Sun; Jinghui Huang; Zhuojing Luo
Journal:  Tissue Eng Part A       Date:  2015-04       Impact factor: 3.845

10.  Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells.

Authors:  Arvind Kumar; Tryambak D Singh; Santosh K Singh; Satya Prakash
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.